LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ß Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models.

LyP-1-Modified Oncolytic Adenoviruses Targeting Transforming Growth Factor ß Inhibit Tumor Growth and Metastases and Augment Immune Checkpoint Inhibitor Therapy in Breast Cancer Mouse Models. Hum Gene Ther. 2020 08; 31(15-16):863-880.

View in: PubMed

subject areas

Adenoviridae
Animals
Bone Neoplasms
Breast Neoplasms
Combined Modality Therapy
Female
Genetic Vectors
Humans
Mice
Mice, Nude
Middle Aged
Oncolytic Virotherapy
Protein Tyrosine Phosphatase, Non-Receptor Type 22
Transforming Growth Factor beta
Tumor Cells, Cultured
Xenograft Model Antitumor Assays

authors with profiles

Kathy Mangold
Hans Schreiber
Karen Kaul